PAPER
Cu–Al Hydrotalcite: An Efficient and Reusable Ligand-Free Catalyst
2521
13C NMR (75 MHz, CDCl3): d = 23.2, 28.1, 33.9, 51.0, 113.6,
118.9, 131.0, 153.1, 169.5.
13C NMR (75 MHz, CDCl3): d = 49.4, 66.9, 117.0, 125.0, 129.1,
150.0.
GC-MS: m/z = 219 (M+).
GC-MS: m/z = 198 (M + H).
Anal. Calcd for C13H17NO2: C, 71.21; H, 7.81; N, 6.39. Found: C,
71.25; H, 7.17; N, 6.41.
Anal. Calcd for C10H12ClNO: C, 60.76; H, 6.12; N, 7.09; Found: C,
60.68; H, 5.99; N, 7.10.
1-Phenyl-1H-imidazole (2a)11
4-(4-Bromophenyl)morpholine (2v)
1H NMR (300 MHz, CDCl3): d = 7.21 (br s, 1 H), 7.29 (br s, 1 H),
7.34–7.40 (m, 3 H), 7.46–7.51 (m, 2 H), 7.87 (s, 1 H).
1H NMR (300 MHz, CDCl3): d = 3.12 (t, J = 4.47 Hz, 4 H), 3.81 (t,
J = 4.47 Hz, 4 H), 6.71 (d, J = 8.80 Hz, 2 H), 7.35 (d, J = 8.80 Hz,
2 H).
13C NMR (75 MHz, CDCl3): d = 118.2, 121.3, 127.4, 129.7, 130.1,
135.5, 137.1.
GC-MS: m/z = 144 (M+).
13C NMR (75 MHz, CDCl3): d = 46.2, 66.9, 112.9, 118.1, 133.8,
148.7.
MS (EI): m/z = 95, 115, 133, 138, 164, 166, 186, 208, 223, 242
Anal. Calcd for C9H8N2: C, 74.98; H, 5.59; N, 19.43. Found: C,
75.15; H, 5.58; N, 19.41.
(M+), 244 (M + 2 H).
Anal. Calcd for C10H12BrNO: C, 49.61; H, 5.00; N, 5.79; Found: C,
49.62; H, 5.01; N, 5.88.
1-(4-Methoxyphenyl)-1H-imidazole (2g)11
1H NMR (400 MHz, CDCl3): d = 3.87 (s, 3 H), 6.99–7.02 (m, 2 H),
7.21 (s, 1 H), 7.23 (s, 1 H), 7.29–7.34 (m, 2 H), 7.80 (s, 1 H).
Acknowledgment
13C NMR (100 MHz, CDCl3): d = 55.6, 114.8, 118.7, 123.1, 130.0,
130.7, 135.8, 158.9.
GC-MS: m/z = 174 (M+).
R.A. wishes to thank DST (GAP-0152) for financial support and
Department of Science and Technology for providing research fel-
lowship.
Anal. Calcd for C10H10N2O: C, 68.95; H, 5.79; N, 16.08. Found: C,
68.99; H, 5.78; N, 16.41.
References and Notes
4-Phenylmorpholine (2r)14c
1H NMR (300 MHz, CDCl3): d = 3.17 (t, J = 4.47 Hz, 4 H), 3.63 (t,
J = 4.47 Hz, 4 H), 6.57–6.60 (m, 3 H), 6.85 (t, J = 7.20 Hz, 2 H).
(1) (a) Lam, P. Y. S.; Clark, C. G.; Saubern, S.; Adams, J.;
Winters, M. P.; Chan, D. M. T.; Combs, A. Tetrahedron
Lett. 1998, 39, 2941. (b) Combs, A. P.; Saubern, S.;
Rafalski, M.; Lam, P. Y. S. Tetrahedron Lett. 1999, 40,
1623. (c) Lam, P. Y. S.; Vincent, G.; Clark, C. G.; Deudon,
S.; Jadhav, P. K. Tetrahedron Lett. 2001, 42, 3415.
(d) Collman, J. P.; Zhong, M.; Zhang, C.; Costanzo, S.
J. Org. Chem. 2001, 66, 7892.
(2) (a) Kiyomori, A.; Marcoux, J. F.; Buchwald, S. L.
Tetrahedron Lett. 1999, 40, 2657. (b) Klapars, A.; Antilla,
J. C.; Huang, X.; Buchwald, S. L. J. Am. Chem. Soc. 2001,
123, 7727. (c) Antilla, J. C.; Klapars, A.; Buchwald, S. L.
J. Am. Chem. Soc. 2002, 124, 11684. (d) Antilla, J. C.;
Baskin, J. M.; Barder, T. E.; Buchwald, S. L. J. Org. Chem.
2004, 69, 5578.
(3) (a) Cristau, H. J.; Cellier, P. P.; Spindler, J. F.; Taillefer, M.
Eur. J. Org. Chem. 2004, 69, 695. (b) Cristau, H. J.; Cellier,
P. P.; Spindler, J. F.; Taillefer, M. Chem. Eur. J. 2004, 10,
5607.
(4) (a) Cai, Q.; Zhu, W.; Zhang, H.; Zhang, Y.; Ma, D. Synthesis
2005, 496. (b) Ma, D.; Cai, Q. Synlett 2004, 128.
(5) (a) Ohmori, J.; Shimizu-Sasamata, M.; Okada, M.;
Sakamoto, S. J. Med. Chem. 1996, 39, 3971. (b) Antonini,
I.; Cristalli, G.; Franchetti, P.; Grifantini, M.; Martelli, S.
Synthesis 1983, 47.
(6) (a) Lindley, J. Tetrahedron 1984, 40, 1433. (b) Kiyomori,
A.; Marcoux, J. F.; Buchwald, S. L. Tetrahedron Lett. 1999,
40, 2657. (c) Hassan, J.; Sevignon, M.; Gozzi, C.; Schulz,
E.; Lemaire, M. Chem. Rev. 2002, 102, 1359.
(7) (a) Ma, D.; Cai, Q.; Zhang, H. Org. Lett. 2003, 5, 2453.
(b) Zang, H.; Cai, Q.; Ma, D. J. Org. Chem. 2005, 70, 5164.
(8) (a) Lu, Z.; Twieg, R. J.; Huang, S. D. Tetrahedron Lett.
2003, 44, 6289. (b) Lu, Z.; Twieg, R. J. Tetrahedron 2005,
61, 903. (c) Zang, Z.; Mao, J.; Zhu, D.; Wu, F.; Chen, H.;
Wan, B. Tetrahedron 2006, 62, 4435.
(9) (a) Xu, L.; Zhu, D.; Wu, F.; Wang, R.; Wan, B. Tetrahedron
2005, 61, 6553. (b) Zhu, D.; Wang, R.; Xu, J.; Mao, J.; Xu,
L.; Wu, F.; Wan, B. J. Mol. Catal. A: Chem. 2006, 256, 256.
(c) Shafir, A.; Buchwald, S. L. J. Am. Chem. Soc. 2006, 128,
8742.
13C NMR (75 MHz, CDCl3): d = 45.8, 99.9, 113.9, 117.0, 126.0,
126.9, 129.0, 133.1, 143.7, 148.2.
GC-MS: m/z = 164 (M + H).
Anal. Calcd for C10H13NO: C, 73.59; H, 8.03; N, 8.58; Found: C,
73.62; H, 8.05; N, 8.61.
4-(4-Nitrophenyl)morpholine (2s)
1H NMR (300 MHz, CDCl3): d = 3.20 (t, J = 4.49 Hz, 4 H), 3.67 (t,
J = 4.49 Hz, 4 H), 6.89 (d, J = 8.39 Hz, 2 H), 8.02 (d, J = 8.39 Hz,
2 H).
13C NMR (75 MHz, CDCl3): d = 46.4, 66.7, 115.2, 123.2, 138.3,
156.1.
MS (EI): m/z = 51, 57, 77, 91, 104, 120, 134, 150, 161, 177, 1293,
208 (M+).
Anal. Calcd for C10H12N2O3: C, 57.68; H, 5.81; N, 13.45; Found: C,
57.66; H, 5.79; N, 13.60.
4-(2-Nitrophenyl)morpholine (2t)
1H NMR (300 MHz, CDCl3): d = 3.15 (t, J = 4.24 Hz, 4 H), 3.85 (t,
J = 4.24 Hz, 4 H), 7.10 (t, J = 7.63 Hz, 1 H), 7.15 (d, J = 8.49 Hz, 1
H), 7.51 (t, J = 6.78 Hz, 1 H), 7.80 (d, J = 8.49 Hz, 1 H).
13C NMR (75 MHz, CDCl3): d = 51.9, 66.7, 120.8, 122.1, 125.7,
133.4, 143.5, 145.6.
MS (EI): m/z = 51, 65, 77, 92, 105, 119, 133, 145, 161, 174, 191,
208 (M+).
Anal. Calcd for C10H12N2O3: C, 57.68; H, 5.81; N, 13.45; Found: C,
58.01; H, 5.80; N, 13.41.
4-(4-Chlorophenyl)morpholine (2u)15c
1H NMR (300 MHz, CDCl3): d = 3.11 (t, J = 4.80 Hz, 4 H), 3.85 (t,
J = 4.80 Hz, 4 H), 6.80–6.84 (d, J = 8.94 Hz, 2 H), 7.21 (d, J = 8.94
Hz, 2 H).
Synthesis 2009, No. 15, 2517–2522 © Thieme Stuttgart · New York